Abstract A previous study claimed a differential behavioural resilience between spring or summer honey bees (Apis mellifera) and bumble bees (Bombus terrestris) after exposure to syrup contaminated with 125 µg L −1 imidacloprid for 8 days. The authors of that study based their assertion on the lack of body residues and toxic effects in honey bees, whereas bumble bees showed body residues of imidacloprid and impaired locomotion during the exposure. We have reproduced their experiment using winter honey bees subject to the same protocol. After exposure to syrup contaminated with 125 µg L −1 imidacloprid, honey bees experienced high mortality rates (up to 45%), had body residues of imidacloprid in the range 2.7-5.7 ng g −1 and exhibited abnormal behaviours (restless, apathetic, trembling and falling over) that were significantly different from the controls. There was incomplete clearance of the insecticide during the 10-day exposure period. Our results contrast with the findings reported in the previous study for spring or summer honey bees, but are consistent with the results reported for the other bee species.
Introduction
A former paper by Cresswell et al. (Cresswell et al. 2014) claimed that newly eclosed honey bees (Apis mellifera) are able to clear completely the insecticide imidacloprid ingested in syrup at a concentration of 125 µg L −1 (w/v), whereas bumble bees (Bombus terrestris) had small amounts of imidacloprid residues in their bodies (2.4 ng per bee) and experienced sublethal effects such as locomotion and feeding impairment. The authors contend that "the greater feeding rate of bumblebees may be the principle cause of their susceptibility rather than a deficiency in detoxification capacity", but in a similar experiment published earlier ) they "speculate that honey bees are better pre-adapted than bumble bees to feed on nectars containing synthetic alkaloids, such as imidacloprid, by virtue of their ancestral adaptation to tropical nectars in which natural alkaloids are prevalent." However, their results do not agree with previous and later research on the toxicity of this neonicotinoid insecticide to bees conducted by either the manufacturers (e.g. Bayer Co.) or independent researchers, which indicate that imidacloprid concentrations in syrup above 20 ng g −1 (ppb) cause a reduction in foraging activity in honey bees (Schmuck et al. 2001 ), while concentrations above 50 ng g −1 alter the foraging behaviour (Ramirez-Romero et al. 2005; Yang et al. 2008) . Some of the latter effects involve changes in the olfactory conditioning of the proboscis extension and learning performance, both of which are about three times more sensitive in summer honey bees than in winter bees, with lowest observable effects of 12 and 48 ng g −1 , respectively (Decourtye et al. 2003) . Other authors have found impairment of certain motor functions such as losing postural control and failing to right themselves after a fall, whereas other behaviours (e.g. walking, sitting and flying) are not significantly affected at sublethal doses. Such changes in motor function after exposure to imidacloprid are always dose-dependent (Williamson et al. 2014) . Besides, feeding activity of honey bees is known to decrease significantly with imidacloprid (Yang et al. 2008) even at concentrations as low as 6 ng g −1 (Colin et al. 2004 ). These and other sublethal effects have been observed (Desneux et al. 2007 ) whenever honey bees are treated with this insecticide at dietary concentrations below those used by Cresswell et al. (2014) . The same effects have been observed in bumble bees exposed to this insecticide Moffat et al. 2016; Thompson et al. 2015 ). An efficient protection of managed pollinators (e.g. honey bees) and wild pollinators (e.g. bumble bees) requires well established knowledge of pesticide effects and metabolism, because the effects could be specific for particular bee species. However, hypothesis on particular mechanisms should be supported by robust evidence, this especially in terms of honey bee type (spring, summer, winter bees) because effects of pesticides can be delayed in time when destocking contaminated food resources. Hence, our purpose here is to reproduce the experiment carried out by Cresswell et al. (2014) but using winter honey bees and extending our observations to additional lethal and sublethal effects. We only tested honey bees, since the results for bumble bees that they reported were consistent with other studies using the same insecticide Moffat et al. 2016 ). We did not intend, however, to study the metabolic profile of imidacloprid in honey bees in more detail than they did (e.g. no metabolites were analysed), because it is known from previous studies (Suchail et al. 2004a; Suchail et al. 2004b ). Equally, this study did not aim at determining the toxic dose-response of imidacloprid on honey bees, as this information is already known (Blacquière et al. 2012; Cresswell 2011) .
Experimental methods
The study was conducted following the same experimental design described by Cresswell et al. (2014) , except that we used winter honey bees (Apis mellifera) instead of "newly eclosed worker honey bees". Briefly, two groups of nine cages (6.5 × 8.5 × 10.5 cm) containing ten honey bees each were used for control and treatment, respectively. The treatment group was fed syrup (500 g L −1 sucrose) containing 125 μg L −1 (w/v; 109 μg kg −1 or ppb) imidacloprid (analytical standard, Cluzeau Info-Labo, Sainte Foy la Grande, France) and the control group just untreated syrup. To avoid possible imidacloprid degradation that could occur during the experimental period, aliquots of the sucrose solutions, containing imidacloprid or not (i.e. control), were frozen and stored at −80°C. Each day, a fresh feeding solution was provided to the bees by thawing aliquots of sucrose solutions containing or not imidacloprid. The concentrations of imidacloprid in the feeding solution was checked by chemical analyses performed before and after freezing at −80°C. The measured concentration of the toxicant was within 10% (RSD) of the nominal concentration and no change in concentration was observed after freezing during the entire experimental period (n = 4). The cages were held in a room at 27 ± 2°C and 70% relative humidity with a light:night cycle of 12:12 h, and monitored daily for food consumption, mortality and behaviour during 10 days. We replicated the experiment with another two groups of 9 cages setup and monitored exactly the same way but each cage contained 30 honey bees. Nine of those cages were monitored daily for mortality and food consumption, whereas the remaining cages were used for chemical analysis of the bees on days 0, 2, 4, 6, 8 and 10. Feeders were replaced with fresh syrup every day, with all groups being fed the same syrup prepared on the first day. Feeding consumption was measured daily by weighing the syrup left in the feeders, and was corrected by the number of surviving bees each day. The experiment started in November 28, 2014 at the facilities of the Laboratory of Environmental Toxicology of INRA (Avignon, France). Therefore, all the bees tested were winter bees, which are less susceptible to imidacloprid than spring or summer bees (Decourtye et al. 2003) . The differential susceptibility to toxicants between summer and winter honey bees can be explained by the lack of foraging activity of workers during the winter period, which imposes variable physiological responses. For behavioural studies, 9 different endpoints were considered: locomotor activity/ mobility, which correspond to the ability of walking, climbing and performing short flights; activity, which is distributed into quietness (normal activity compared to control), hyperactivity (rapid and badly controlled movements associated with fast displacements) and apathy (motionless bees); tremors; falls from the walls of the cage; trophallaxis; ventilation (wing beating as bees are static) and feeding behaviour. Video tracking was used for recording the activity of the bees according to the methodology previously published (Colin et al. 2004; Teeters et al. 2012) . The bees of each cage were followed for 5 min five times per day: at 9:30, 10:00, 10:30, 11:00 and 11:30.
After the toxicity tests, all bees were immediately frozen and kept at −24°C until chemical analyses of imidacloprid, as the aim of the study was to test whether residues of the parent compound would remain in the bees body during the testing period. Two g of honey bees (approximately 16-17 bees) were sampled on alternate days, as mentioned above, and analysed for neonicotinoids at the Centre de Biophysique Moléculaire (CNRS, France). A blank matrix was provided from a local professional apiary located in a wooded area. The HPLC-MS/MS analytical method was adapted from Bonmatin et al. (Bonmatin et al. 2003) . Briefly, after homogenization, extraction was performed with 10 mL of acetone, with internal standard added (imidacloprid-D4), stirring, recovery and evaporation of the supernatant. Then, the extract was dissolved in acetonitrile and 2% of acetic acid. A volume of 70 µL was mixed with 130 µL of mobile phase (water/methanol 65:35 and 2% of acetic acid). Twenty µL were injected in HPLC (C18) with a run time of 9 min. MS/MS analysis was performed in the APCI mode on a triple Quad 5500 mass spectrometer (SCIEX). The method has been fully validated for analysis of imidacloprid, thiamethoxam, clothianidin, acetamiprid and thiacloprid in insects (Drosophila and bees) according to the DG SANCO 12571/2013 criteria for confirmatory methods. More specifically, imidacloprid was detected through its parent ion at m/z 256 and two fragments ions at m/z 209 and m/z 175, while the internal standard was used for specificity and quantification criteria using the same fragmentations. Linear coefficients of determination (r 2 ) were always greater than 0.98 for 5 calibration points in the range 0.5-25 ng g −1 . Recovery rates calculated for three levels (each level analysed twice) were always between 80 and 90%. According to the full set of quality criteria, limits of detection (0.1 ng g −1 body weight) and quantification (0.5 ng g −1 b.w.) correspond approximately to 12 and 60 pg per bee, respectively. Statistical comparisons of feeding rates, residue levels and behavioural activities between controls and treatments were performed using paired t-tests. In all cases, α = 0.05. The apparent half-life of imidacloprid parent compound in honey bees during 10 days of chronic exposure was determined by least-squares linear regression of the imidacloprid levels in bees (log transformed) over the time series. All data analyses were performed using the StatPlus package of Excel software.
Results
Syrup consumption was not different (p = 0.55, two-tailed t-test) in the control cages containing either 10 or 30 bees, averaging 42 ± 17 mg per bee and 38 ± 17 mg per bee respectively over the 10 days of exposure. Feeding rates in the treated cages were similar, with average consumption of 48 ± 22 mg per bee and 35 ± 15 mg per bee in the cages containing 10 and 30 bees, respectively. There was no difference in syrup consumption between the control and treated groups (paired t-test: p = 0.57 for 10 bees per cage; p = 0.70 for 30 bees per cage).
Mortality
The mortality rates of control honey bees after 10 days were 24% in the cages with 10 bees and 23% in cages with 30 bees, showing no difference between them. Such rates are considered normal for winter bees (Alkassab and Kirchner 2016; Decourtye et al. 2003) . Honey bees that fed on syrup contaminated with imidacloprid showed significantly higher mortality than bees in the controls during the same period: 71 and 61% for cages with 10 and 30 bees, respectively (Fig. 1) . Thus, bee mortality was 41-47% higher in the treated cages than in the controls after 10 days of exposure.
Residues of imidacloprid in bees
Bees from the control cages did not have any detectable residues of imidacloprid (i.e. <0.1 ng g −1 ) at any time during the experiment. By contrast, honey bees from the syrup-treated cages (30 bees per cage) had measurable levels of imidacloprid in the range 5.7-2.7 ng g −1 (values not corrected for recovery rates) between days 2 and 10. No other neonicotinoid (thiamethoxam, clothianidin, acetamiprid and thiacloprid) was found, both in control and treated bees. Based on the consumption rate, the average daily intake of imidacloprid was 3.8 ± 2.0 ng per bee, but the cumulative Fig. 1 Cumulative mortality of winter honey bees exposed to imidacloprid during 10 days. Nine cages of either 10 or 30 bees were fed daily a sucrose solution containing 125 µg L −1 imidacloprid (squares) or not (circles). Error bars represent standard deviations intake of imidacloprid during the 10-day period was curvilinear ( Fig. 2) because individual intake was highest on day 1 (6.6 ± 2.4 ng per bee) and lowest on the last day of the experiment (1.3 ± 1.2 ng per bee), as previously reported (Colin et al. 2004) . Considering the cumulative intake over the experimental period, body residues of imidacloprid on day 2 (0.68 ± 0.04 ng per bee) represent 6% of the cumulative intake to that day, whereas at the end of the 10-day period the residues (0.32 ± 0.01 ng per bee) were 0.9% of the total intake (Fig. 2) . Considering that the metabolism of this insecticide in honey bees is very fast, with an estimated half-life of 4 or 5 h (Suchail et al. 2004a) , at the end of each day 98% of imidacloprid would have been converted into various metabolites (Suchail et al. 2004b ) and only 2% would remain in the bees' bodies. That is why it is pertinent to compare the body residues of imidacloprid found each day to the intake for the same day. Residues of imidacloprid on day 2 were 10.3% of the intake for that day alone, whereas on the last day of the experiment the proportion of parent imidacloprid increased to 24.1% of that day's intake ( Table 1 ). The increase of this relative proportion of imidacloprid suggests a slowdown of its metabolism with exposure time, which had passed un noticed until now, and explains the incomplete clearance of the parent compound at the end of the 10-day exposure period.
It is noteworthy that imidacloprid levels in honey bees have always been above the limit of quantitation (0.5 ng g −1 body weight) during our experiment. The decrease in the parent imidacloprid level during this period enabled estimation of a pseudo-apparent half-life of 7.6 days in bees that consumed daily contaminated syrup at 125 μg L −1 . This contrasts with previously reported half-lives for this insecticide of 4 or 5 h after a single exposure (Suchail et al. 2004a ). Our estimated half-life results from concomitant detoxification processes and chronic intake, neither of which is constant over time, not only because honey bees did not consume contaminated food regularly but also because detoxification efficiency is dependent on the internal amounts of the parent insecticide and its metabolites.
Behavioural effects
Nine different behaviours were monitored daily in the cages containing 10 bees: locomotor activity or mobility, quietness, hyperactivity, apathy, tremors, falls from the walls of the cage, trophillaxis, ventilation and feeding. Four of these behaviours showed significant differences (p < 0.05, paired ttest) between control and treated bees: honey bees were more often restless, exhibited trembling, were apathetic and often fell from the walls when exposed to imidacloprid (Fig. 3) . It is noteworthy that these differences generally appeared after 1 day of chronic exposure, and changes in behaviours were not constant or related to time. For instance, the four behaviours described above were more strongly affected on days 4 and 5. Apathy was also observed while bees were previously hyperactive because hyperactivity is generally followed by tranquillity in chronic exposure (Suchail et al. 2001) . Fig. 2 Exposure profile of honey bees chronically exposed to imidacloprid. The honey bees were exposed to imidacloprid by feeding a sucrose solution containing 125 µg L −1 for 10 days. The cumulative intake of imidacloprid (squares) was calculated on the basis of food consumption and imidacloprid concentration. Body residues in the treated bees (ng per bee) were quantified by HPLC-MS/MS (triangles); error bars (see Table 1 ) are too small to be displayed on a log scale. For controls (circles), imidacloprid intake was null and its residues were always below the limit of detection of 0.1 ng g −1 (i.e. <12 pg per bee). The stippled line corresponds to a linear regression on the body residues (y = 0.726 -0.092LnX, r 2 = 0.68), used to estimate the apparent half-life (7.6 days) of this insecticide in honey bees Data represent mean values ± SD. For daily intake n = 9, and for residues in bees n = 3. The percentage of residues was calculated from the residues at given days and (i) the cumulative imidacloprid intake until the day (% cumulative intake); or (ii) the daily intake of imidacloprid on a given day, on the assumption that the majority (~98%) of the previous intake had been metabolised
The feeding activity was less frequent in exposed honey bees (average 3.7% bees) than in controls (6.7% bees), although not statistically significant (p = 0.07, paired t-test). No noticeable difference in general mobility (locomotion, p = 0.21), trophallaxis (p = 0.73) and ventilation (p = 0.47) behaviours was observed between controls and imidaclopridexposed honey bees (data not shown).
Discussion
Our experiments were performed with winter honey bees, which are less sensitive to imidacloprid and other insecticides than the spring or summer honey bees (Decourtye et al. 2003; Meled et al. 1998 ) used by Cresswell et al. (2014) . They also used smaller cages (240 cm 3 ) than ours (580 cm 3 ) under conditions of lower relative humidity (21-47% compared to 70% in our case). However, these two technical variations are not expected to have any significant bearing on the toxicological effects and the metabolism of a potent insecticide like imidacloprid.
In our experiment, honey bees that fed on syrup containing 125 μg L −1 imidacloprid died earlier and at a higher rate compared to bees that were fed untreated syrup (Fig. 1) . After 2 days of exposure, the average corrected mortality rates in the treated cages were 38-46% (Fig. 1) , whereas in the control cages mortality was 2 to 7%. After 10 days, the mortality rate in the treatments was still about three times higher than in the controls for a total intake of 38.2 ng imidacloprid per bee. This exemplifies the strong effect of this concentration of imidacloprid on mortality even after a short exposure Fig. 3 Behavioural effects in honey bees chronically exposed to imidacloprid. Data points are percentage of honey bees (mean ± SE) showing the corresponding behaviour from daily observations (n = 5) in nine cages. The behaviours of activity (quietness, apathy), trembling and falling showed statistically significant differences (p < 0.05, paired t-test) between control (circles) and treated bees (squares). In regard to activity, all non-quiet bees were hyperactive or restless period: each bee had consumed in 2 days an average 11.4 ng of imidacloprid (Fig. 2) , an amount close to its 48-h oral LD50, which is typically in the range 30-60 ng per bee (Blacquière et al. 2012) , although some Bayer studies (Schmuck et al. 2001) have reported it as 4-41 ng per bee. This is not surprising, since sensitivity towards neonicotinoids among honey bees from different genetic backgrounds can differ by a 33-fold factor (Rinkevich et al. 2015) or even more (Suchail et al. 2001 ).
According to a meta-analysis of toxicity data on imidacloprid for honey bees (Cresswell 2011) , the total dose ingested by our bees in 2 days would have caused about 70% mortality (Fig. 1c in Cresswell 2011 ). Since winter bees are known to be less sensitive to toxicants than the newly eclosed bees usually tested, our results are consistent with the findings of that meta-analysis. Under similar conditions, Cresswell et al. (2014) reported a lower average consumption of 2.2 ng of imidacloprid per day by their worker bees, which would have produced about 20-25% mortality in 2 days. Note that the total dosage of 17 ng per bee in their 8-day experiment is about half the LD50 for honey bees.
We found bodily residues of imidacloprid parent compound in measureable amounts (2.7 to 5.7 ng g −1 )
throughout the entire exposure period (Fig. 2) . The discrepancy between our results and the ones reported by Cresswell et al. (2014) may have different explanations. (i) Spring or summer bees, used by those authors, may present a higher metabolism than winter bees. This would result in a lower concentration of imidacloprid residues. However, this hypothesis is not supported by the lower sensitivity of winter bees that generally results from an increased metabolism and, in turn, a lower level of pesticide residues (Crailsheim 1986 ).
(ii) In our study, 2 g samples were used (16-17 bees per sample at 0.12 g per honey bee). However, in the study of Cresswell et al., the starting sample mass was low, about 0.42 mg of honey bees, and imidacloprid was extracted from a single bee (0.14 g per bee) and then 3 extracts were pooled before analysis. Given the large variation in residue amounts usually found from bee to bee, smaller sample sizes can lead to greater variability of detections than larger samples. This agrees with the fact that using a higher sample mass of about 0.57 mg for bumble bees, the same authors were able to detect and quantify imidacloprid. (iii) The recovery rates of the analytical method used by Cresswell et al. were only 64% for honey bees and 52% for bumble bees and were measured with internal standard added after extraction, not enabling the assessment of the actual recovery rate, which is necessarily lower. (iv) In Cresswell et al. (2014) imidacloprid concentrations in the syrup fed to the bees were nominal and not actual concentrations confirmed by analysis. Thus, a risk of under exposure cannot be completely ruled out.
The amount of imidacloprid residues in our bees declined with time (Fig. 2) . This is probably due to a combination of the induction of detoxifying enzymes during daily chronic exposure and a reduction of the feeding behaviour (Yang et al. 2008 ). Syrup consumption rates in the cages with 30 bees were five times lower in the last day (12 ± 11 mg per bee) than in the first day (61 ± 20 mg per bee), explaining in part the slowdown in mortality observed after the first day (Fig. 1) . The decline in body residues is also consistent with partial metabolism leading to the production of multiple metabolites, some of which are known to be toxic to honey bees (Suchail et al. 2004a; Suchail et al. 2001 ) and may account for some of the toxic effects observed. Contrasting with our observations, Cresswell et al. (2014) reported feeding rates that remained practically constant over time in newly eclosed summer honey bees (Fig. 2a in Cresswell et al. 2014) .
It has been shown that, when honey bees are chronically exposed to 0.16 ng per day of imidacloprid (i.e. an exposure 24 times lower than in our experiment or 14 times lower than that in Cresswell et al. (2014) ), the toxic effects are still present and even increase after certain time, despite the fact that more than 90% of the parent compound is metabolised (Rondeau et al. 2014) . Our data here show that 1-6% of imidacloprid parent compound remains in the bees, with its daily proportion increasing over time (Table 1 ). In spite of the rapid metabolism of this insecticide in honey bees, there was incomplete clearance of imidacloprid in our honey bees and residues of this neurotoxicant remained above the quantifying level in the bees' bodies, which is consistent with the lethal and behavioural effects observed. More generally, there is no evidence of unusually high metabolism in this species of bees. On the contrary, honey bees seem to exhibit a deficit of detoxification mechanisms (Claudianos et al. 2006 ) that makes them as sensitive to pesticides as bumble bees by either oral or contact exposure (Arena and Sgolastra 2014; Marletto et al. 2003; Thompson 2016) or even more sensitive (Hardstone and Scott 2010; Sánchez-Bayo and Goka 2014) . As a matter of fact, our winter honey bees displayed symptoms of intoxication similar to those exhibited by the bumble bees in Cresswell et al. (2014) .
In our experiment, intoxicated honey bees moved only slightly less than the control bees, with no statistical difference among them (locomotion, p = 0.21). Our results suggest that trembling, restlessness, apathy and falling over may be more sensitive endpoints than walking for assessing sublethal effects of imidacloprid in honey bees (Fig. 3) . Indeed, the locomotor activity (walking) in cages, may not be suitable for studying sublethal toxic effects in bees, as other authors have shown that 100 µg L −1 of imidacloprid in syrup caused significant motion impairment in honey bees only within the first 3 h, but not afterwards (Medrzycki et al. 2003) . Cresswell et al. (2014) reported that worker honey bees neither experienced any adverse effects (lethal or locomotion) nor present residues in their bodies after feeding during 8 days on syrup containing a biological active concentration of imidacloprid (125 μg L −1 ). We could not reproduce their findings using winter bees and the same methods used by those authors. Any lack of residues and effects strongly suggest under exposure. It can be assumed that the spring or summer bees they used would exhibit similar or more pronounced effects than winter bees because of their higher sensitivity to pesticides, but, as already indicated, decreased sensitivity to toxicants typically involves a higher detoxifying metabolism (Crailsheim 1986 ). Hence, bodily residues are expected to be lower in winter bees than in summer bees. The absence of residues in summer bees contrasts with reports by other authors (Bacandritsos et al. 2010; Bortolotti et al. 2009; CalatayudVernich et al. 2016; Dively et al. 2015; Hladik et al. 2016) , who have shown that residues of imidacloprid can be quantified in summer honey bees exposed to environmental levels of this insecticide, which are typically lower than those tried in this study and in that of Cresswell et al. (2014) .
Conclusions
We reproduced the experiments of Cresswell et al. (2014) using winter honey bees and our results differ completely from those reported by those authors. We found that imidacloprid parent compound is present in honey bees at measureable levels when they are fed syrup contaminated with this insecticide at 125 µg L −1 . The presence of imidacloprid in honey bees was revealed right from the beginning of the exposure and remained measurable during 10 days. The parent imidacloprid residues decreased slightly and progressively, with an apparent half-life of 7.6 days, which is about 36 times longer than the half-life estimated after a single exposure (Suchail et al. 2004a; Suchail et al. 2004b ). Therefore, there was not a 100% clearance of imidacloprid in winter honey bees. Furthermore, when comparing the residues of imidacloprid with its daily intake, we observed an increase of the relative amount of the chemical in the bees, which suggest an adverse effect on their detoxification ability. Chronic exposure of winter honey bees to imidacloprid did not induced a significant change in mobility (locomotion), as reported also by Cresswell et al. (2014) for spring or summer honey bees. However, such an exposure induced a strong lethal effect on the second day (38-46% mortality) and mortality remained three times higher than that of the controls during the 10 days of our experiment. This level of exposure also induced typical sublethal effects on honey bees (restless, trembling, apathetic and falling over) that were statistically significant (p < 0.05), whereas the decrease in the feeding activity was found less significant. Therefore, both lethal and sublethal effects of imidacloprid were observed in winter honey bees.
Further experiments, considering several levels of exposure with spring, summer and winter honey bees, could be very useful to better understand the effects of imidacloprid or other neonicotinoids, as well as their metabolism in honey bees.
